Search for: "House v. Janssen Research "
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
11 Jan 2011, 11:07 pm
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
4 May 2017, 1:00 am
Relevant Judicial Practice Boehringer Ingelheim Pharma GmbH & Co KG v. [read post]
10 May 2020, 4:28 pm
All the Courts’ updates on the Coronavirus guidance can be found on the Courts and Tribunal Judiciary Hacked off had a press release “Hacked Off research reveals extent of relentless intrusion on singer Jesy Nelson”. [read post]
25 Jan 2017, 10:48 pm
Birss J agreed with Floyd J in Actavis v Janssen [2008] EWHC 1422 (Pat) that the presence of another fairly remote possibility did not preclude a finding of “inevitable result”. [read post]
21 Feb 2021, 4:07 pm
Published in Internet Policy Review (18 December 2020), 9(4), pp 1 – 25; https://doi.org/10.14763/2020.4.1536 , Heleen Janssen, University of Cambridge – Computer Laboratory, Jennifer C [read post]
3 Sep 2015, 6:36 am
Housing Auth. of Baltimore City, 984 F.2d 622 (4th Cir. 1993), didn’t deal with the FDA at all, but with “HUD’s 1992 Formal Utility Review. [read post]
27 Dec 2011, 9:56 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
7 Mar 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO upholds one of Wisconsin Alumni Research Foundation (WARF’s) human stem cell patents (decisions are pending on two other patents): (IPKat), (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (Patent Baristas), (IPBiz), English High Court rules Qualcomm’s patents invalid in battle against Nokia: (Philip Brooks),… [read post]
11 Jul 2008, 4:30 am
: (IP Business Strategy Blog) Global - Copyright LegalTorrents – ‘online community created to discover and distribute CC licensed digital media’: (creativecommons.org), WIPO workshop to probe copyright issues arising from the preservation of digital content: (WIPO), Jeff Roberts on avatar rights: (IPKat) Events 16 July: US LSI ‘Patent claim construction workshop’ – Seattle: (Patent Docs), 16-17 July: EPO seminar on… [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
1 Oct 2009, 2:14 am
We discussed Fields v. [read post]
29 Aug 2016, 1:19 pm
Risperdal is the name Janssen patented and used when marketing the product. [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
